Tel Aviv Medical Center — Tel Aviv

Public research footprint of Tel Aviv Medical Center, compiled from the ClinicalTrials.gov public registry.

159

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Refractory B-Cell Non-Hodgkin Lymphoma · Parkinson Disease · Metastatic Head-and-neck Squamous-cell Carcinoma · Refractory Mantle Cell Lymphoma (MCL)

Recently updated registry entries

NCT06680830 — A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive… (Recruiting)
NCT03025308 — Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With… (Completed)
NCT06973187 — A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tel Aviv Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.